ARTICLE | Company News
Incyte, Pharmasset deal
August 29, 2005 7:00 AM UTC
Pharmasset received a $1.5 million milestone payment from INCY under a 2003 deal in which INCY received exclusive development and marketing rights to Pharmasset's Reverset reverse transcriptase inhibi...